Phobia, Social: Clinical Trials

363 trials for Phobia, Social, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

240 completed, 43 recruiting, 32 unknown, 19 terminated. 228 Not applicable, 49 Phase 2, 34 Phase 3, 24 Phase 4, 16 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable228Completed 141, Recruiting 36, Unknown 25, Active not recruiting 9, Terminated 8, Not yet recruiting 6, Withdrawn 2, Suspended 1
Phase 249Completed 44, Recruiting 2, Withdrawn 2, Unknown 1
Phase 334Completed 25, Active not recruiting 3, Terminated 3, Unknown 2, Withdrawn 1
Phase 424Completed 16, Terminated 4, Recruiting 3, Unknown 1
Phase 116Completed 11, Terminated 2, Withdrawn 2, Unknown 1
Early Phase 15Completed 3, Terminated 1, Unknown 1

Follow Phobia, Social: new trials by email Literature Review of Phobia, Social trials Research Report on Phobia, Social

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Uncovering Neurocognitive Mechanisms and Enhancement of Exposure-based Fear Learning With Cognitive Training
Cognitive training - Anxiety, Fear Extinction
Not applicableNot yet recruitingUniversity of California, San Diego1202027-01-012026-09-04
Caplyta Versus Placebo for Adults With Social Anxiety Disorder
Lumateperone 42 mg, Placebo - Social Anxiety Disorder (SAD)
Phase 4RecruitingJason Careri402026-09-102026-09-15
Efficacy of Expectancy Focused Exposure Therapy for Anxiety Disorders
Expectancy Focused Exposure, Anxiety Focused Exposure - Anxiety Disorders, Panic Disorder
Not applicableRecruitingUniversity of Chile2032026-07-012026-08-07
Efficacy of Attention Bias Modification vs. Placebo for Social Anxiety Disorder
Dot-Probe Attention Bias Modification (ABM), Placebo Training - Social Anxiety Disorder (SAD), Attention Bias Modification Treatment (ABMT)
Not applicableRecruitingTel Aviv University902026-06-152026-06-24
Safety Behavior Fading Versus Progressive Muscle Relaxation for Appearance Concerns
Safety Behavior Fading for Appearance Concerns, Progressive Muscle Relaxation - Body Dysmorphic Disorder, Eating Disorders
Not applicableActive not recruitingFlorida State University3002026-05-292026-09-30
Effectiveness of an AI-Integrated Proactive Thought Control Intervention for Young Adults With Social Anxiety Disorder
AI-Proactive thought control, Cognitive Behavior Therapy, Active Control - Social Anxiety Disorder (SAD)
Not applicableCompletedFarah Shahzadi752026-03-142026-09-09
Brief Interpretation Bias Modification for Social Anxiety Disorder in Pakistani Young Adults: An Experimental Evaluation
WSAP-based interpretation bias modification, WSAP interpretation control condition - Social Anxiety Disorder, Interpretation Bias
Not applicableNot yet recruitingAther Mujitaba1302026-02-012026-02-12
Testing a Precision Psychotherapy System for Low-income Patients
Pre-treatment psychotherapy recommendations - Major Depressive Disorder, Dysthymic Disorder
Not applicableNot yet recruitingNational Council of Scientific and Technical Research, Argentina1112026-02-012021-11-18
Metacognitive Therapy Compared to Cognitive-behavioral Therapy
Transdiagnostic metacognitive therapy, Disorder-specific cognitive-behavioral therapy - Generalized Anxiety Disorder, Social Anxiety Disorder
Not applicableRecruitingKarolinska Institutet302026-01-282026-08-18
Stepped Care Treatment for Anxiety Resilience
Relaxation and Mentorship Training (RMT), Stepped Care Targeting Exposure and Parenting for Anxiety (STEP-A) - Generalized Anxiety Disorder (GAD), Social Anxiety Disorder (SAD)
Not applicableRecruitingAndrew Wiese1062026-01-052026-03-02
An Examination of the Performance of QbMobile in Differential Diagnosis Associated With ADHD Symptoms
Digital software application for cognitive performance and activity measurement (QbMobile, investigational device) - Bi-Polar Disorder, Autism Spectrum Disorder (ASD)
SuspendedQbtech AB3002026-01-012026-09-25
Online Radical Acceptance Intervention for Social Anxiety Disorder
Radical Acceptance, Relaxation Skills - Social Anxiety Disorder (SAD)
Not applicableRecruitingUniversity of Haifa1002025-12-162026-05-06
Internet-Delivered Cognitive Behavioral Intervention for Youths With Anxiety Disorders
Internet-Delivered Cognitive Behavioral Therapy - ANXIETY DISORDERS (or Anxiety and Phobic Neuroses), Specific Phobia
Not applicableRecruitingLund University482025-12-122026-02-20
Intermittent Theta Burst Stimulation of the Prefrontal Cortex in Social Anxiety Disorder
Active Intermittent Theta-Burst Stimulation (iTBS), Sham Intermittent Theta-Burst Stimulation (iTBS) - Social Anxiety Disorder (SAD)
Not applicableRecruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine1002025-12-092026-03-12
A Study of NTX-1472 in Social Anxiety Disorder
NTX-1472, Placebo - Social Anxiety Disorder (SAD)
Phase 2RecruitingNewleos Therapeutics, Inc.1002025-12-092026-07-09
Testing Delivery Modalities of Team-Based CBT for Pediatric Anxiety in Community Health Settings.
Team-delivered, exposure-based CBT - Obsessive Compulsive Disorder (OCD), Pediatric Anxiety Disorders
Not applicableRecruitingBradley Hospital5012025-11-012026-07-31
Virtual Reality Based Cognitive Behavioral Therapy for Social Anxiety Among Youths in Hong Kong
VR intervention - Social Anxiety Disorder (SAD), Social Phobia
Not applicableNot yet recruitingHong Kong Shue Yan University902025-11-012025-09-15
Anxiety Skills Study
Cognitive therapy, Behavioral therapy, Mindfulness-based therapy - Anxiety, Anxiety Acute
Not applicableRecruitingOhio State University6002025-10-202026-08-19
Using TMS to Understand Neural Processes of Social Motivation
TMS - Social Avoidant Behavior, Major Depressive Disorder
Not applicableRecruitingAuburn University402025-09-302026-03-03
Study to Evaluate the Efficacy and Safety of VQW-765 for the On-Demand Treatment of Social Anxiety Disorder
VQW-765, Placebo - Social Anxiety Disorder (SAD)
Phase 3Active not recruitingVanda Pharmaceuticals5002025-09-222026-08-17

Showing 20 of 363. Sign in to see all of them.

Narrower conditions

Anxiety Disorders (132)  ·  Generalized Anxiety Disorder (119)  ·  Panic Disorder (80)  ·  Obsessive-Compulsive Disorder (43)  ·  Anxiety, Separation (40)  ·  Agoraphobia (39)  ·  Stress Disorders, Post-Traumatic (32)  ·  Phobia, Specific (30)  ·  Depression (25)  ·  Depressive Disorder, Major (25)  ·  Phobic Disorders (24)  ·  Dysthymic Disorder (12)  ·  Psychological Well-Being (10)  ·  Autism Spectrum Disorder (9)

Broader conditions

Mental Disorders (357)  ·  Phobic Disorders (339)  ·  Anxiety Disorders (231)  ·  Neurodevelopmental Disorders (56)  ·  Behavior (43)  ·  Mood Disorders (38)  ·  Trauma and Stressor Related Disorders (34)  ·  Stress Disorders, Traumatic (31)  ·  Behavioral Symptoms (26)  ·  Depressive Disorder (26)  ·  Pathological Conditions, Signs and Symptoms (16)  ·  Chemically-Induced Disorders (15)  ·  Child Development Disorders, Pervasive (15)  ·  Signs and Symptoms (13)  ·  Nervous System Diseases (12)

Interventions

Cognitive Behavioral Therapy (47)  ·  Therapeutics (11)  ·  Paroxetine (10)  ·  Sertraline (10)  ·  Implosive Therapy (8)  ·  Quetiapine Fumarate (6)  ·  Virtual Reality Exposure Therapy (6)  ·  Cannabidiol (5)  ·  Cycloserine (5)  ·  Waiting Lists (5)  ·  Dexetimide (4)  ·  Escitalopram (4)  ·  Exercise (4)  ·  Sugars (4)  ·  Autogenic Training (3)

Sponsors

GlaxoSmithKline (11)  ·  Karolinska Institutet (9)  ·  Tel Aviv University (9)  ·  Florida State University (7)  ·  Massachusetts General Hospital (7)  ·  University of California, Los Angeles (7)  ·  University of South Florida (7)  ·  University of Texas at Austin (7)  ·  New York State Psychiatric Institute (6)  ·  University of Michigan (6)  ·  VistaGen Therapeutics, Inc. (6)  ·  University of California, San Diego (5)  ·  Babes-Bolyai University (4)  ·  Baylor College of Medicine (4)  ·  Boston University Charles River Campus (4)

Countries

United States (185)  ·  Canada (29)  ·  Sweden (25)  ·  Israel (14)  ·  Germany (13)  ·  United Kingdom (11)  ·  Denmark (10)  ·  Norway (10)  ·  Romania (7)  ·  China (5)  ·  Netherlands (5)  ·  Turkey (Türkiye) (5)  ·  Brazil (4)  ·  Japan (4)  ·  Pakistan (4)

Top investigators

Yair Bar-Haim, PhD (7)  ·  Michael Van Ameringen, MD, FRCPC (6)  ·  Arun Ravindran, MD, PhD (4)  ·  Eric A Storch, Ph.D. (4)  ·  Franklin Schneier, MD (3)  ·  Per Carlbring, PhD (3)  ·  Per Carlbring, Professor (3)  ·  Angela Fang, PhD (2)  ·  Daniel F Gros, PhD MA BS (2)  ·  Diana Koszycki, PhD (2)  ·  Elizabeth Hoge, MD (2)  ·  Gerhard Andersson, Professor (2)  ·  Gisele G Manfro, MD, PhD (2)  ·  Jasper Smits, Ph.D. (2)

Results publications

PMID 42743597, PMID 24098630, PMID 2885745, PMID 31430688, PMID 34693989, PMID 38754336, PMID 40208666, PMID 10052767, PMID 12694427, PMID 14584861, PMID 15157814, PMID 15330942, PMID 15341364, PMID 15562916, PMID 15691340, PMID 16268999, PMID 16540816, PMID 17539717, PMID 17891261, PMID 18030084, PMID 18974308, PMID 19157776, PMID 19212970, PMID 19222311, PMID 19508270, PMID 19829198, PMID 20013046, PMID 20018493, PMID 20046862, PMID 20051130, PMID 20146834, PMID 20206470, PMID 20483968, PMID 21367351, PMID 21391024, PMID 21464362, PMID 21483704, PMID 21676694, PMID 21762829, PMID 22122292, PMID 22152230, PMID 22233247, PMID 22245618, PMID 22304968, PMID 22320999, PMID 22348135, PMID 22362158, PMID 22404963, PMID 22420873, PMID 22647314

NIH funding

P50MH080215 (2), R01MH075889 (2), R01MH076074 (2), R34MH073004 (2), R34MH100468 (2), 2014 (1), 2016 (1), 2018 (1), 2023 (1), 2025 (1), F32MH129076 (1), K01MH072952 (1), K23DA048181 (1), K23MH076198 (1), K23MH133063 (1)